18 November 2026 (Wednesday) - IBMS Update

The IBMS sent its newsletter today. You can read it by clicking here. It has to be said that generally I’m not that complimentary about the IBMS, and this newsletter wasn’t one of their better ones, but it would seem that our professional regulator is looking for people to sit on fitness to practise panels.

I wonder if I could do that?

 

17 November 2026 (Tuesday) - Westgard QC Update


The nice people at Westgard QC sent their update today. You can read it by clicking here. It’s rather heavy going, but then, statistics usually are.
I say that every time I get one of their updates, don't I?

13 November 2026 (Friday) Blood Doc Dad

 I found this bloke on Facebook. I’ve also found a load of flat-Earthers, anti-vax loonies and religious crackpots on there so I know what I’m likely to find but this bloke is (according to Google) “a board-certified hematologist and oncologist with over a decade of clinical experience.”

He might be a source of CPD, he might not. Time will tell. It always does.


12 November 2026 (Thursday) - BTLP-TACT Exercise

Can you believe it – the nice computer at BTLP-TACT have told me I’m not doing enough. I had a look at my individual dashboard which said I’m supposed to have done four cases in the last month and I’ve actually done nine. Bearing in mind the thing clearly can’t count to four, I have to question those antibody identifications it says I missed antibodies in.
But whilst I’m at it I might as well do another case. It gave me two…
 
91653 – a thirty-two year-old woman in theatre needing group and save.
She grouped as A Rh(D) Positive… was that supposed to be a weak reaction? I called the Rh group indeterminate event though it wasn’t.
The antibody screen was positive in cells 1 & 3 so I performed antibody panels.
The IAT panel was positive in cells 1, 3, 6, 9 & 10 corresponding with anti-Fy(a)
The enzyme panel was negative throughout.
 
12769 – a fifty-five year-old chap in A&E with epistaxis.
He grouped as B Rh(D) Positive with antibody screen positive in cells 2 & 3 so I performed antibody panels.
The IAT and enzyme panels were positive in cells 3, 4, 5, 6, 7, 8, 9 and 10 corresponding with anti-c but not excluding anti-E, anti-Lu(a) or anti-Kp(a)
 
I got the thumbs-up…

12 November 2026 (Thursday) - Horiba Update

The nice people at Horiba sent their update today. You can read it by clicking here.
There was a very good review of the diagnosis of AML… and then a frankly wrong bit of advice about dealing with platelet clumping.
Given a numerically very low platelet count and a blood film showing a normal platelet count albeit with platelets appearing clumped you should not report the numerically very low platelet count. There’s two reasons for this. The numerically very low platelet count is clearly wrong and misleading, and the numerically very low platelet count is clearly wrong and misleading. OK, that’s the same reason, but it is so important I thought I should say it twice.
Given platelet clumping with what can clearly be seen to be an adequate platelet count one should report it as “platelets are clumped but appear to be present in normal numbers” (or something along those lines) and then ask for a sample collected into a different anticoagulant. Reporting a frankly wrong platelet count can easily lead to unnecessary, unwarranted (and potentially dangerous) outcomes.
 
There’s a lesson to be learned here… This is from an official update from a respected source. Even the best of us can make mistakes.

 

10 November 2026 (Tuesday) - Back In The Day

Back in the day I used to go to the haematology clinic in Folkestone on a Friday morning where I would perform manual platelet counts using one of these. That was forty years ago... the things are still in use in some labs...


9 November 2026 (Monday) - BTLP-TACT Exercise

Can you believe it - I got yet another snarky email saying I’m not doing enough BTLP-TACT exercises so here we go again…
I was presented with two cases:
 
86241 – a seventy-three year-old chap with alcoholic liver disease needing group and save.
He grouped as O Rh(D) Positive with antibody screen positive in all three cells. I performed antibody screens. The enzyme screen was positive in cells 3 and 5 corresponding with anti-E, and the IAT screen was positive in cells 1, 3, 5, 6, 9 & 10 corresponding with anti Fy(a).
 
76686 – a forty-one year-old chap with sepsis also needing group and save.
He grouped as Rh(D) Positive but the ABO group was indeterminate. With a cell group of A but a reverse group of O, this is one for NHSBT.
His antibody screen was negative though.
 
I got the thumbs-up…

 

9 November 2026 (Monday) - PNH (?)


Well, let’s apply a process of elimination…
The patient is older than me (and I’m ancient) so any condition is unlikely to be a hereditary one.
Having a bone marrow aspiration is traumatic (I’ve seen it done)
So that leaves flow cytometry and cytogenetics.
Bearing in mind from the symptoms it looks like the patient has PNH, the standard test would be flow cytometry to evaluate CD55 and CD59 levels…

The correct answer is 2
Paroxysmal nocturnal hemoglobinuria is an acquired clonal disorder caused by somatic mutations of the PIGA gene that result in impaired production of the glycosylphosphatidylinositol (GPI) anchor on blood cells. The resulting GPI-anchor deficiency can affect multiple haematopoietic lineages. Clinically, patients present with complement-mediated intravascular hemolysis, thrombosis, and bone marrow failure. Diagnosis is established by flow cytometry demonstrating populations of GPI-deficient blood cells.  

Reference:
Fattizzo B, Marchetti M, Cannizzo E, et al. Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments. European Journal of Haematology. 2026.
 

Interested in receiving LearningMonday questions to your inbox? Subscribe here: https://eha.fyi/subscribe  

8 November 2026 (Sunday) - Slide Saturday Challenge

 They are hairy cells... aren't they?
(Apparently not called that any more in the twenty-first century!!!)


7 November 2026 (Saturday) - Neutropenic?

For a long time it has been common knowledge that “people of African origin” have lower neutrophil counts than the general UK public. It would seem that this isn’t strictly true… it is actually people with the Duffy-null phenotype.
New reference ranges have been drawn up for neutrophil counts for these people. There’s an article on it here.
However this begs the question of how do we know where and when to apply this reference range? Should we be performing Duffy phenotyping as part of a chronic neutropenia screen?

 

5 November 2026 (Thursday) - BTLP-TACT Exercise


 I got another snarky email saying I’m not doing enough BTLP-TACT exercises so I thought I’d better do one…
It gave me two cases:
 

44549 – a forty-six year-old woman in maternity needing group and save.

She grouped as O Rh(D) Negative with antibody screen weakly positive in cells 1 & 2 so I performed antibody panels. The enzyme and IAT panels were positive in cells 1, 2 & 3 corresponding with anti-D but not excluding anti-Cw

74466 – a seventy-six year-old woman needing four units of blood for a revision of THR.

She grouped as O Rh(D) Positive with a negative antibody screen. I selected four units of O Rh(D) Positive blood.

 
I got the thumbs up

5 November 2026 (Thursday) - UKAS Update

The nice people at UKAS sent their incomprehensible gibberish today. Am I being cynical? Click here and judge for yourself.
I then copied the entire lot into Microsoft CoPilot and asked for an English translation. And again starting off with what really was a load of incomprehensible gibberish I ended up with something rather more sensible.
As I’ve said before, quality management would be taken far more seriously if it wasn’t couched in such silly words. 

3 November 2026 (Tuesday) - Fritsma Factor Update

The Fritsma Factor newsletter appeared in my in-box today. This one does get published as a website to which I can link… so here’s the link. I like thinks I can link to – it’s evidence that I’m not just making it up.
 
There’s quite a bit of technical stuff in this month’s update. Bearing in mind that I finished formal training in 1987 and Factor V Leiden was first described in 1994, I personally find the Fritsma Factor update invaluable.

2 November 2026 (Monday) - The Blood Project

A while ago I signed up to the mailing list of “The Blood Project”. As I said to the boss last week, I sign up to pretty much every work-related mailing list there is. I was going to say “most turn out to be a load of rubbish” but that’s rather unfair. To be honest what I do is rather specialized and so most medical mailing lists are incredibly useful to those at whom they are aimed, but just a tad irrelevant to me.
The October newsletter arrived today (in November!). I would give a link to it, but this is just an email… it’s rather clinical but that’s not necessarily a bad thing. Thalassemia, haemophilia… all useful stuff. It would just be nice to have some technical stuff in amongst the clinical.

 

2 November 2026 (Monday) - Learning Monday

 

The correct answer: is 3.

Thromboembolism occurs one in every five patients with myeloproliferative neoplasms (MPNs). The incidence of splanchnic vein thrombosis (SVT) in patients varies and can affect mortality and morbidity. Active gastrointestinal bleeding occurring as a result of portal hypertension and or with anticoagulant therapy in these patients requires immediate stabilization and control of the bleeding source. The timing of anticoagulation resumption or initiation must account for hemostasis, rebleeding risk, thrombus extent and progression, and the patient's overall clinical condition. Cytoreductive therapy does not replace anticoagulation when anticoagulation is indicated. Long-term anticoagulation is frequently needed due to the risk of recurrent thrombosis and the other risk factors for thrombosis. Discontinuing anticoagulation can still be a difficult decision. There is no universally applicable time point for restarting anticoagulation after acute variceal bleeding in every patient with MPN-SVT. The decision requires multidisciplinary assessment, often involving hematology, hepatology and gastroenterology.  

References:  
1. Demirci U, Baysal M, Aksoy E, et al. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study. J Thromb Thrombolysis. 2026 Aug 7. doi: 10.1007/s11239-026-03363-8. 
2. Baysal M, Bayrak M, EÅŸkazan AE. Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review. Expert Rev Hematol. 2023 Feb;16(2):131-140. 
3. How C, Chrysafi P, Ko A, et al. Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN). Blood. Volume 144, 2024, Page 16.  

Interested in receiving LearningMonday questions to your inbox? Subscribe here: https://eha.fyi/subscribe  


1 November 2026 (Sunday) - BTLP-TACT Exercise

Bearing in mind I’ve had yet another whinging email about how few BTLP-TACT exercises I’ve done (only six last month!!) I thought I might see if I could get ahead of the curve this month.
I was presented with two cases:
 
90063 – a forty-five year-old woman in the haematology clinic with sickle cell disease needing a two unit top up.
She grouped as O Rh(D) Positive with a negative antibody screen. I selected two units of O Rh(D) Positive K-Negative HbS-Negative blood for her.
 
06929 – a fifty-nine year-old chap with PR bleed needing group and save.
He grouped as A Rh(D) Positive with a negative antibody screen.
 
I got it right, which was a result.

1 November 2026 (Sunday) - ITP

Here’s an interesting little overview of the state of treatment of ITP. Back in the mid-eighties I used to go to the haematology clinic of a satellite hospital on a Friday morning where I would do a couple of dozen (manual) platelet counts. We had many patients with ITP whose platelet counts were often in single figures. I can remember may of those people being one big bruise.

How times have changed…

29 October 2026 (Thursday) - HCPC Update

The nice people at the HCPC sent their update today. The bit about next year’s CPD week struck me as potentially rather useful. Back in the day I would have got really involved with it. Back in the day I used to organize weekly CPD sessions. Part of me wondered about revisiting that, but motivating the disinterested was hard work. Do I want to start all that again?

I shall just keep an eye out for anything that might be useful to me… but (sadly) reading the rest of their update, my hopes aren’t high.